Optiver Holding’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.81K Sell
1,910
-1,948
-50% -$5.82K ﹤0.01% 1933
2026
Q1
$11.9K Buy
+3,858
New +$16.4K ﹤0.01% 1188
2025
Q2
Sell
-247
Closed -$1.24K 1450
2025
Q1
$1.24K Buy
247
+39
+19% +$247 ﹤0.01% 1263
2024
Q4
$1.5K Sell
208
-356
-63% -$2.72K ﹤0.01% 961
2024
Q3
$3.46K Sell
564
-326
-37% -$2.21K ﹤0.01% 826
2024
Q2
$5.92K Buy
+890
New +$6.57K ﹤0.01% 780

Other funds holding ALT

Optiver Holding's ALT Position: Q2 2026 in Review

Optiver Holding reduced its Altimmune (ALT) stake by 50% in Q2 2026, selling an estimated $5.82K and leaving 1,910 shares worth $5.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

Optiver Holding first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $11.9K in Q1 2026. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Optiver Holding held 1,910 shares of Altimmune worth $5.81K as of Q2 2026.
  • Optiver Holding sold 1,948 Altimmune shares in Q2 2026, an estimated $5.82K.
  • Altimmune made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1933 holding.
  • Optiver Holding first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
  • Optiver Holding's Altimmune position peaked at $11.9K in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.